PCV96 Cost-Utility Analysis of the Long-Term Cardiovascular Prevention Program in Russian Federation as an Argument for the Widespread Introduction of Preventive Technologies Into Clinical Practice (Englisch)
- Neue Suche nach: Kontsevaya, A.
- Neue Suche nach: Kalinina, A.
- Neue Suche nach: Deev, A.
- Neue Suche nach: Kontsevaya, A.
- Neue Suche nach: Kalinina, A.
- Neue Suche nach: Deev, A.
In:
VALUE IN HEALTH
;
14
, 7
;
A381
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PCV96 Cost-Utility Analysis of the Long-Term Cardiovascular Prevention Program in Russian Federation as an Argument for the Widespread Introduction of Preventive Technologies Into Clinical Practice
-
Beteiligte:
-
Erschienen in:VALUE IN HEALTH ; 14, 7 ; A381
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:A381
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 14, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A234
-
DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control: A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation ModelAlam, M. / Briggs, A. et al. | 2011
- A235
-
PC2 Estimation of Productivity Costs Using the Friction Cost Method: New Evidence Using National DataErdogan-Ciftci, E. / Koopmanschap, M. A. et al. | 2011
- A236
-
PR3 Industry Preparedness against German reformsDevienne, E. / White, R. / Mukku, S. et al. | 2011
- A237
-
MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data: An Efficient Use of Evidence for Cost-Effectiveness ModellingSaramago, P. / Sutton, A. J. / Cooper, N. J. / Manca, A. et al. | 2011
- A238
-
UT1 Combining DCE and TTO Into A Single Value FunctionVan Hout, B. A. / Oppe, M. et al. | 2011
- A239
-
VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma: Cost-Effectiveness and Value of informationSoini, E. J. / Martikainen, J. A. / Vihervaara, V. / Mustonen, K. / Nousiainen, T. et al. | 2011
- A241
-
MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients: Results from A Cross-Sectional Study in the United States and Four European CountriesKay, S. / Tolley, K. / Globe, D. / Piercy, J. / Anderson, P. et al. | 2011
- A242
-
MO2 Extrapolation in Oncology Modelling: Novel Methods for Novel CompoundsAnnemans, L. / Asukai, Y. / Barzey, V. / Kotapati, S. / Lees, M. / Van Baardewijk, M. / Wang, Q. / Batty, A. J. / Fisher, D. et al. | 2011
- A243
-
RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In EuropeCerri, K. / Ferná / ndez, J. L. / Knapp, M. et al. | 2011
- A244
-
PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in DevelopmentHaakma, W. / Bojke, L. / Steuten, L. / Ijzerman, M. et al. | 2011
- A247
-
PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in DystoniaPr Coubes, P. / Fluck, L. / Topouchian, A. et al. | 2011
- A248
-
PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in SpainFerreira-Gonzá / lez, I. / Serra, V. / Abdul, O. / Lizan, L. / Paz, S. / Banz, K. / Sureda, C. / Igual, A. / Garcia del Blanco, B. et al. | 2011
- A249
-
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal OriginCastell, J. / Bernal, C. / De Marcos, J. x. / Cugat, E. / Ramó / n, E. / Tellado, J. M. et al. | 2011
- A250
-
PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in FranceDe jong, L. / Lafuma, A. / Clé / ment, O. / Aguade, A. S. / Berdeaux, G. et al. | 2011
- A251
-
PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile NeutropaeniaShabaruddin, F. H. / Elliott, R. A. / Tappenden, P. / Payne, K. et al. | 2011
- A253
-
PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury PatientsBruce, S. / Lö / froth, E. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. et al. | 2011
- A254
-
PMD59 Complicated Parkinson'S Disease: Discrete Choice Analysis to Assess Patients' Preferences. A Pilot StudyLloyd, A. J. / Herdman, M. / Gonzalez, P. et al. | 2011
- A255
-
PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg): The Case of Drug-Eluting Stents in Patients with Acute Myocardial InfarctionBä / umler, M. et al. | 2011
- A257
-
PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care EnvironmentVisnansky, M. / Mesaros, S. et al. | 2011
- A258
-
PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient DatabaseHargreaves, J. A. / Nair, K. V. / Ghushchyan, V. H. / Allen, R. R. / Mcqueen, R. B. / Robinson, T. et al. | 2011
- A259
-
PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder SymptomsMargolis, M. K. / Coyne, K. / Jumadilova, Z. et al. | 2011
- A260
-
PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis: An International Analysis of Clinical OutcomesSmith, J. C. / Provencher, M. T. / Solomon, D. J. / Navaie, M. et al. | 2011
- A261
-
PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in GermanyAlvarez-Ossorio, L. / Burkowitz, J. / Nackunstz, I. / Brueggenjuergen, B. et al. | 2011
- A262
-
PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and BelgiumSennfalt, K. / Ling, C. / Pericleous, L. / Sbarigia, U. / Gatta, F. / Kolasa, K. / Zagorska, A. / Chamberlain, G. / Pandit, P. et al. | 2011
- A263
-
PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of TreatmentsPayakachat, N. / Suen, J. Y. et al. | 2011
- A264
-
PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric BypassMar, J. / Arrospide, A. / Mar, B. / Martinez de Aragó / n, G. / Karlsson, J. et al. | 2011
- A265
-
PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults: A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R, Lopinavir/R, and EfavirenzVerheggen, B. / Vandeloise, E. / Treur, M. / Thuresson, P. O. / Lescrauwaet, B. et al. | 2011
- A266
-
PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection in TurkeyOzdemir, O. / Saylan, M. / Pakel, H. / Lescrauwaet, B. et al. | 2011
- A267
-
PIN13 Epidemiology of Staphylococcus Aureus Infections in Children: A Literature Review of the Last 10 YearsBricout, H. / Maier, W. / Mouchet, J. et al. | 2011
- A268
-
PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)Gwiosda, B. / Krzystek, J. / Rys, P. / Wladysiuk, M. / Mierzejewski, P. / Kazmierski, M. / Plisko, R. et al. | 2011
- A269
-
PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health AdministrationChan, K. / Lai, M. N. / Groessl, E. J. / Hanchate, A. / Hernandez, L. / Wong, J. B. / Clark, J. A. / Asch, S. / Gifford, A. L. / Ho, S. et al. | 2011
- A270
-
PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in UgandaKuznik, A. / Semeere, A. / Sempa, J. / Auerbach, B. / Lamorde, M. / Castelnuovo, B. / Hermans, S. / Ssewankambo, F. / Ssennono, M. / Mpanga Sebuyira, L. et al. | 2011
- A271
-
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World DataDelissovoy, G. / Pan, F. / Patkar, A. D. / Edmiston, C. E. / Peng, S. et al. | 2011
- A272
-
PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral DrugsMiller-Jansö / n, H. E. / Stander, M. et al. | 2011
- A274
-
PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in PolandMacioch, T. / Paweska, J. / Niewada, M. / Berak, H. / Szkultecka-Debek, M. / Russel-Szymczyk, M. et al. | 2011
- A275
-
PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)Pepe, C. / Teich, V. / Mould, J. F. et al. | 2011
- A276
-
PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in PanamaLutz, M. A. / Luciani, K. / Morales, G. / Strutton, D. R. / Roberts, C. S. / Farkouh, R. A. / Cuesta, G. et al. | 2011
- A277
-
PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in RussiaOmelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Ivakhnenko, O. / Goryaynov, S. / Tsfasman, F. M. et al. | 2011
- A278
-
PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients: Country Results for Italy, Spain, Portugal and UKThuresson, P. O. / Verheggen, B. / Heeg, B. / Aldir, I. / Carrasco, J. / Didoni, G. / Mesa, O. A. / Lescrauwaet, B. et al. | 2011
- A279
-
PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the NetherlandsMeijboom, M. / Rozenbaum, M. / Benedictus, A. / Luytjes, W. / Kneyber, M. / Wilschut, J. / Hak, E. / Postma, M. et al. | 2011
- A280
-
PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in PolandKawalec, P. / Holko, P. / Boratynska, M. / Glyda, M. / Ignacak, E. / Russel-Szymczyk, M. / Szkultecka-Sebek, M. / Kaweczynska-Lason, A. et al. | 2011
- A282
-
PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B PatientsHaq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. et al. | 2011
- A283
-
PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of PertussisRozenbaum, M. H. / De vries, R. / Postma, M. J. / Le, H. H. et al. | 2011
- A284
-
PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in ThailandLayton, M. R. / Pachanee, K. / Prakongsai, P. et al. | 2011
- A285
-
PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A VaccineFaure, C. / Koller, A. / Hartmann, K. / Chré / tin, S. / Doux, S. / Visè / le, N. / Bugnard, F. / Maier, W. et al. | 2011
- A286
-
PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS: A Meta-Analysis Combining Published and Unpublished DataBallesteros, J. / Tarapues, M. / Santos, B. / Rueda, J. R. et al. | 2011
- A287
-
PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder: Indirect Comparisons at Twelve WeeksSapin, C. / Corson, H. / Beillat, M. / Hansen, K. et al. | 2011
- A288
-
PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral OlanzapineNovick, D. / Ascher-Svanum, H. / Bertsch, J. / Detke, H. / Mcdonnell, D. / Witte, M. / Haro, J. et al. | 2011
- A289
-
PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland: Aanalysis of the Impact on the Health Care SystemFaluta, T. / Rdzanek, M. / Pierzgalska, K. / Wró / bel, B. et al. | 2011
- A290
-
PMH23 The Economic Burden of Mental Ill Health in the Workplace: A Costing Approach for Brazilian EmployersReis, T. C. / Takemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Cukier, F. N. / Santos, P. M. / Cruz, R. B. / Ribeiro, A. C. / Fernandes, R. R. et al. | 2011
- A291
-
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant TherapyAydemir, O. / Dilbaz, N. / Malhan, S. et al. | 2011
- A292
-
PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in NorwayEinarson, T. R. / Vicente, C. / Zilbershtein, R. / Piwko, C. et al. | 2011
- A293
-
PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in AustraliaO'Leary, B. A. / Hamann, G. B. / Adena, M. A. et al. | 2011
- A294
-
PMH46 The Quality of Life of Children With ADHD and their Parents: Results of EQ-5D and Kidscreen-10Van Der Kolk, A. / Bouwmans, C. / Schawo, S. / Buitelaar, J. B. / van der Gaag, R. J. / Van agthoven, M. / Hakkaart-van Roijen, L. et al. | 2011
- A295
-
PMH51 Measuring Relapse After Substance Abuse Treatment: A Proportional Hazard ApproachCiesla, J. / Mazurek, K. et al. | 2011
- A296
-
PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia: Analysis of Catie DataRabinowitz, J. / Garibaldi, G. / Levine, S. / Bugarski-Kirola, D. / Berardo, C. / Kapur, S. et al. | 2011
- A297
-
PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and ItalySikirica, V. / Mitra, D. / Fridman, M. / Davis, K. L. / Hodgkins, P. et al. | 2011
- A298
-
PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United StatesChen, Y. J. / Sankaranarayanan, J. / Murman, D. L. et al. | 2011
- A300
-
PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in IndiaNagappa, A. N. / Kumar, M. / Noorunnisa, S. / Bhandary, P. V. / Veerupaksh, D. / Balakrishnan, R. et al. | 2011
- A301
-
PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States: Where are the Differences?Cuervo, J. / Rebollo, P. / Maurino, J. / Cordero, L. / Castejó / n, N. et al. | 2011
- A303
-
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the ElderlySebestyé / n, A. / Sá / ndor, J. / Patzai, B. / Gõ / cze, K. / Kriszbacher, I. / Mintá / l, T. et al. | 2011
- A304
-
PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured PopulationSchabert, V. / Gandra, S. R. / Watson, C. / Fox, K. M. / Yeaw, J. / Goodman, S. / Milev, S. / Harrison, D. J. et al. | 2011
- A305
-
PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech RepublicPetrikova, A. / Klimes, J. / Dolezal, T. / Marinov, L. / Petrova, G. et al. | 2011
- A307
-
PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United KingdomPericleous, L. / Lebmeier, M. et al. | 2011
- A308
-
PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in ColombiaFernandes, R. A. / Tovar, D. A. / Mould, J. F. et al. | 2011
- A309
-
PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in AustraliaTilden, D. / Jackson, D. / Tay-Teo, K. / Van Bavel, J. et al. | 2011
- A310
-
PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in SpainVilloro, R. / Hidalgo, A. / Ferro, B. / Talavera, P. et al. | 2011
- A311
-
PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid ArthritisAdams, R. C. / Walsh, C. / Schmitz, S. / Barton, P. / Barry, M. et al. | 2011
- A312
-
PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological TherapyGulacsi, L. / Brodszky, V. / Baji, P. / Gulacsi, L. x. / Pé / ntek, M. et al. | 2011
- A314
-
PMS67 Determining the True Impact of Dupuytren'S Disease: A Qualitative StudyWilburn, J. / McKenna, S. / Crawford, S. R. / Perry-Hinsley, D. / Bayat, A. et al. | 2011
- A315
-
PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated DuloxetineChen, S. Y. / Peng, X. / Wu, N. / Bernauer, M. / Rao, P. / Boulanger, L. / Zhao, Y. et al. | 2011
- A316
-
PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care: A Population-Based Intervention StudyWickizer, T. M. / Franklin, G. M. / Fulton-Kehoe, D. et al. | 2011
- A317
-
PND3 Risk-Benefit Analysis of Therapy in Multiple SclerosisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A318
-
PND9 The Role of Spontaneous Events Databases for Benefit-Risk AnalysisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A319
-
PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along SpainRamos-Goñ / i, J. M. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. / Espada-Sá / enz-Torre, M. / Tellerí / a-Orriols, J. J. et al. | 2011
- A320
-
PND20 A Cost-of-Illness Analysis Of Amyotrophic Lateral Sclerosis In GreeceAthanasakis, K. / Sideris, M. / Zacharis, M. / Rentzos, M. / Evdokimidis, I. / Kyriopoulos, J. et al. | 2011
- A321
-
PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis: The Case of Epilepsy in FranceFagnani, F. / Kusnik-Joinville, O. / de Zé / licourt, M. / Levy-Bachelot, L. / Branchoux, S. / Murat, C. / Bertrand, M. / Kahane, P. et al. | 2011
- A322
-
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) DeficiencyTilden, D. / Cottrell, S. / Tocchini, L. / Jayaram, N. / Sinani, R. / Barnes, D. et al. | 2011
- A323
-
PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III TrialO' / Connor, P. / Briggs, A. / Carita, P. / Bego-Le-Bagousse, G. et al. | 2011
- A324
-
PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)Clay, E. / Briquet, B. / Aballea, S. / Maman, K. / Toumi, M. et al. | 2011
- A325
-
PND46 The Huntington Quality of Life Instrument (H-QOL-I): Cross-Cultural Validation in Germany, Poland and USAClay, E. / Mraidi, M. / Zielonka, D. / Cohen, J. / Toumi, M. / Auquier, P. et al. | 2011
- A326
-
PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple SclerosisKhalaf, K. M. / Globe, D. / Armstrong, E. / Malone, D. / Coyne, K. et al. | 2011
- A327
-
PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic ReviewMarfatia, S. / Shroff, K. / Munshi, S. / Tiwari, A. et al. | 2011
- A328
-
PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United StatesPalmer, L. A. / Fowler, R. / Shi, N. / Dastani, H. / Abouzaid, S. / Kim, E. et al. | 2011
- A329
-
PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)Toledo, F. O. / Junior, W. M. / Speciali, J. G. / Sobreira, C. F. et al. | 2011
- A330
-
PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to PlaceboSnedecor, S. J. et al. | 2011
- A331
-
PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)Medina Gó / mez, J. L. et al. | 2011
- A332
-
PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United StatesAggarwal, S. et al. | 2011
- A333
-
PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice ExperimentBaji, P. / Pavlova, M. / Gulacsi, L. / Groot, W. et al. | 2011
- A334
-
PHP9 Temporary Use Authorizations: The Economic and Clinical Future of Drugs Used in the French Compassionate ProgramDegrassat-Thé / as, A. / Paubel, P. / Parent de Curzon, O. / Le Pen, C. / Sinè / gre, M. et al. | 2011
- A335
-
PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics: The Case of Orphan IndicationsWild, L. / Forster, L. et al. | 2011
- A336
-
PHP21 Adoption of New Medicines in the OECD: Regulation, Innovation and ScaleVarol, N. / Costa-i-Font, J. / Mcguire, A. J. et al. | 2011
- A337
-
PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies: Lessons From A Multi-Market Health Technology Assessment and Reimbursement reviewFaulkner, E. C. / Fernandez, M. / Spinner, D. S. et al. | 2011
- A338
-
PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): A Systematic Literature ReviewKarray, S. M. / Plich, A. / Flostrand, S. / Toumi, M. et al. | 2011
- A339
-
PHP37 Regional Drug Evaluation in Spain: A Comparison Among CommitteesHerná / ndez-Pastor, L. J. / Huerta, A. et al. | 2011
- A340
-
PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring CountryKrehic, J. / Gavrankapetanovic, F. / Djapo, M. / Agic, N. et al. | 2011
- A341
-
PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU CountriesPogorilic, S. / Vitezica, P. / Bolanca, S. et al. | 2011
- A342
-
PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid EnrolleesGanduglia, C. / Franzini, L. / Dunn, K. et al. | 2011
- A343
-
PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased AdherenceHicks, K. A. / Karve, S. J. / Vlahiotis, A. / Frazee, S. G. / Tian, Y. / Earnshaw, S. R. et al. | 2011
- A344
-
PHP64 Reorganisation of Hospital Emergency Services: A Business Case for Quality ImprovementEichler, K. / Senn, O. / Rü / themann, I. / Bö / gli, K. / Sidler, P. / Brü / gger, U. et al. | 2011
- A345
-
PHP70 Value Based Pricing (VBP): Is This the Way Forward for the UK NHS?Comberiati, U. / Dass, R. N. / White, N. et al. | 2011
- A346
-
PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA StudyGarrigues, B. / Lefrant, J. Y. / Bazin, J. / Bardoulat, I. / Tagdichti, K. / Courtial, F. / Maurel, F. / Pribil, C. et al. | 2011
- A347
-
PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine: The Belgian CaseDylst, P. / Vulto, A. / Simoens, S. et al. | 2011
- A348
-
PHP86 Incorporating the Patient Perspective Into the Health Care Process: Experience from the C.A.T. Health SystemRebollo, P. / Castejó / n, N. / Cuervo, J. / Igarreta, M. / Ortega, F. et al. | 2011
- A349
-
PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology DrugsOfierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. / Pasierski, T. et al. | 2011
- A350
-
PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (A&E) DepartmentsLaokri, S. / Zhang, W. H. / Ben Hamed, N. / Cohen, L. / De Wever, A. / Alexander, S. et al. | 2011
- A351
-
PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes StrategyAggarwal, S. et al. | 2011
- A352
-
PHP108 Public Health and Prevention in Europe: Is it Cost-Effective?Simoens, S. et al. | 2011
- A353
-
PHP113 Measuring the Organizational Performance in Tennessee: A Case of Community HospitalsRoh, C. Y. / Shirore, R. M. et al. | 2011
- A354
-
PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement SolutionKim, S. / Cho, Y. / Shim, S. / Lee, J. / Kim, W. / Bae, K. et al. | 2011
- A355
-
PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four ContinentsSchwarzer, R. / Rochau, U. / Mü / hlberger, N. / Jahn, B. / Sroczynski, G. / Schnell-Inderst, P. / Schall, I. / Kallinger, S. / Lackner, M. et al. | 2011
- A356
-
PHP129 Societal Preferences for Health Technology Disinvestment Policy: Views of Scottish Taxpayers – A Qualitative StudyHislop, J. M. et al. | 2011
- A357
-
PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical StudentsHettihewa, L. M. / Wimalasena, G. / Tharanga, D. et al. | 2011
- A359
-
PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and ManufacturersCarlson, J. J. / Gries, K. / Sullivan, S. D. / Garrison, L. et al. | 2011
- A360
-
PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care WorkersFerrario, A. / Nicod, E. / Kanavos, P. et al. | 2011
- A361
-
PHP157 Using the CEAC for Value Based Pricing: Don'T Change the GoalpostsRoberts, G. et al. | 2011
- A363
-
PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology AdoptionJena, A. B. / Philipson, T. J. et al. | 2011
- A364
-
PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists: Systematic Review and Meta-Analysis of Randomized Controlled TrialsCorrales-Á / lvarez, I. / Catalá / pez, F. / Martí / n-Serrano, G. / Montero-Corominas, D. / Calvo-rojas, G. et al. | 2011
- A366
-
PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular DiseaseAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A367
-
PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive PatientsAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A368
-
PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United KingdomJones, J. / Townsend, R. / Jameson, K. / Amber, V. / Evans, L. M. et al. | 2011
- A370
-
PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden: The Example of Myocardial InfarctionAhmad Kiadaliri, A. / Clarke, P. M. / Gerdtham, U. G. / Nilsson, P. / Eliasson, B. / Gudbjö / rnsdottir, S. / Steen carlsson, K. et al. | 2011
- A371
-
PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in SpainDarba, J. / Kaskens, L. / Nilsson, J. / Oberdiek, A. et al. | 2011
- A372
-
PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial FibrillationBaser, O. / Wang, L. et al. | 2011
- A373
-
PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro StudyMarti, B. / Delgado, J. / Oliva, J. / Llano, M. / Pascual, P. / Comin, J. / Grillo, J. J. / Diaz molina, B. / Culebras, J. / Martí et al. | 2011
- A376
-
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in GermanyTheidel, U. / Asseburg, C. / Giannitsis, E. / Katus, H. et al. | 2011
- A377
-
PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in GreeceKourlaba, G. / Fragoulakis, V. / Maniadakis, N. et al. | 2011
- A378
-
PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian AnalysisMittmann, N. / Chan, B. / Seung, S. J. / Liovas, A. / Cohen, E. et al. | 2011
- A379
-
PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato TrialGarcia-Castillo, A. / De-los-Rios, M. / Polanco, A. C. / Ramirez, M. A. / Nikolic, E. / Mellströ / m, C. et al. | 2011
- A380
-
PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral ArteryRamos-Goñ / i, J. M. / Mar-Medina, J. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. et al. | 2011
- A382
-
PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence SurveyHudgens, S. / Lynch, J. / Pasquale, K. / Zacker, C. et al. | 2011
- A383
-
PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment: Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available PatientsVilla, L. / Abraham, I. / Macdonald, K. / Denhaerynck, K. et al. | 2011
- A384
-
PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction SurveyOberdiek, A. / Sandberg, A. / Franczok, E. et al. | 2011
- A386
-
PCV123 The Participation Decision for Lifestyle Disease ScreeningSø / gaard, R. / Lindholt, J. / Gyrd-Hansen, D. et al. | 2011
- A387
-
PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation ServiceRose, P. / James, R. / Chapman, O. / Marshall, S. et al. | 2011
- A388
-
PCV134 Concomitant Medciation Use in US Adults on Statin Therapy: Findings from a Multi-Employer Claims DatabaseMolife, C. / Zhu, Y. / Yu, C. / Mccracken, R. / Zhao, Z. et al. | 2011
- A389
-
PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in BrazilNasciben, V. / Piegas, L. S. / Figueiredo, M. J. / Martins, S. C. et al. | 2011
- A391
-
PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver ToxicityGokhale, M. N. / Foster, H. R. / Cleves, M. / Hogan, W. R. / James, L. P. / Martin, B. et al. | 2011
- A392
-
PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United StatesJensen, I. S. / Helm, T. / Cyr, P. L. et al. | 2011
- A393
-
PGI13 Evaluation of the Clinical and Economic Burden of Chronic Constipation in BelgiumLeeuwenkamp, O. / Chevalier, P. / Lamotte, M. et al. | 2011
- A394
-
PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS SettingAreias, J. / Branco, T. / Calinas, F. / Carvalho, A. / Macedo, G. / Manata, M. J. / Matos, L. / Rodrigues, B. / Velosa, J. / Pereira, C. et al. | 2011
- A395
-
PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. et al. | 2011
- A396
-
PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis: Effects of one Year Maintenance Treatment with MMX MesalamineSolomon, D. / Yarlas, A. / Yen, L. / Hodgkins, P. / Karlstadt, R. / Kane, S. V. et al. | 2011
- A397
-
PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative ColitisStark, R. G. / Hunger, M. F. / Reitmeir, P. / Kö / nig, H. H. / Leidl, R. et al. | 2011
- A398
-
PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special PopulationsPaes, B. A. / Li, A. / Lanctot, K. L. / Mitchell, I. et al. | 2011
- A399
-
PIH12 Patients with BPH in France: Results at Six Months with Phytotherapy Versus Other TreatmentsPerrin, P. / Auges, M. / Rahhali, N. / Taieb, C. et al. | 2011
- A400
-
PIH18 Rotavirus Gastroenteritis in Vulnerable Children: A UK Case Control StudyPockett, R. D. / Campbell, D. / Adlard, N. E. / Rajoriya, F. / Carroll, S. M. et al. | 2011
- A401
-
PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and AdolescentsSikirica, V. / Erder, M. / Xie, J. / Macaulay, D. / Diener, M. / Hodgkins, P. / Wu, E. Q. et al. | 2011
- A402
-
PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for ArgentinaEllis, A. / Lepetic, A. C. / Gomez, J. A. et al. | 2011
- A403
-
PIH34 Patient Reported Reasons for Medication Nonadherence: A SurveyLee, K. / Nixon, M. / Cascade, E. / Plummer, C. / Law, V. / Lee, M. et al. | 2011
- A405
-
PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes StudyCarroll, S. / Gater, A. / Abetz, L. / Demuth, D. / Smith, F. / Mannan, A. et al. | 2011
- A406
-
PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011Zawodnik, S. / Kiljan, A. / Hermanowski, T. / Golicki, D. et al. | 2011
- A408
-
PIH62 Comparative Pricing and Reimbursement Analysis in Four East European CountriesPeev, S. / Petrova, G. / Baran, A. / Petrikova, A. / Daneasa, D. et al. | 2011
- A409
-
PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological SurveyLoftus, J. / Ranke, M. / Lindberg, A. / Brosz, M. / Kaspers, S. / Wollmann, H. / Koltowska-Haggstrom, M. / Roelants, M. et al. | 2011
- A410
-
PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis: a Mixed Treatment Meta-AnalysisFan, T. / Bennett, H. / Smith, N. / Marin, M. / Sen, S. et al. | 2011
- A412
-
PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help?Kani, C. / Litsa, P. / Alexopoulou, E. / Hatzikou, M. / Delibasi, S. / Geitona, M. et al. | 2011
- A413
-
PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French ResultsAmoura, Z. / Pennaforte, J. L. / Hamidou, M. / Arfi, S. / Lazaro, E. / Hachulla, E. / Pourrat, J. / Queyrel, V. / Aubin, C. / Garofano, A. et al. | 2011
- A414
-
PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?Pereira, J. / Ribeiro, V. / Mateus, C. et al. | 2011
- A415
-
PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in IrelandObradovic, M. / Ikenberg, R. / Hertel, N. / Liedgens, H. et al. | 2011
- A416
-
PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary CareAra, R. / Blake, L. et al. | 2011
- A417
-
PSY42 Chronic Pain: Patient Treatment Preferences - a Discrete Choice ExperimentMü / hlbacher, A. / Ezernieks, J. / Nü / bling, M. et al. | 2011
- A418
-
PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A PatientsJo, H. / Gringeri, A. / Leissinger, C. / Mantovani, L. / Cortesi, P. / Gemmen, E. et al. | 2011
- A419
-
PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss PharmacotherapyAgatep, B. C. / Charland, S. L. / Herrera, V. / Hawk, G. / Stanek, E. J. et al. | 2011
- A420
-
PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic PainRejas, J. / Ruiz, M. A. / Pardo, A. / Ruiz, L. / Soto, J. et al. | 2011
- A421
-
PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM): Case in Point Prostate CancerAggarwal, S. et al. | 2011
- A422
-
PRM11 Learning Effect in Economic Evaluations of Health Care InterventionsChang, S. / Sungher, D. / Diamantopoulos, A. et al. | 2011
- A423
-
PRM17 Suitability of CLAD-CQR Models for Obtaining QALYsCunillera, O. / Vilagut, G. / Medina, A. / Tresserra, R. / Alonso, J. / Brugulat, P. / Garcí / a, C. / Ferrer, M. et al. | 2011
- A424
-
PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained ResourcesJahn, B. / Rochau, U. / Mü / hlberger, N. / Sroczynski, G. / Conrads-Frank, A. / Siebert, U. et al. | 2011
- A425
-
PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products: Comparison Between Exponential Smoothing and Box-Jenkins MethodsSantos, P. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Fernandes, R. R. / Padula, A. C. / Cukier, F. N. / Cruz, R. B. et al. | 2011
- A426
-
PRM33 Systematic Review of Health State Utilities in SpainGarcí / a-Pé / rez, L. / Aguiar-Ibá / ez, R. / Linertová / R. / Rivero-Santana, A. / Abá / solo-Alessó et al. | 2011
- A428
-
PRM44 The First Research: Assessment of the WTP Threshold for QALY by Contingent Valuation Method in RussiaZelenova, O. et al. | 2011
- A429
-
PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated EndpointsAballea, S. / Vataire, A. L. / Neine, M. E. / Le coroller, G. / Toumi, M. et al. | 2011
- A430
-
PRM55 A New Approach to Modeling Cancer Recurrence and Follow-UpRose, J. / Augestad, K. M. / Cooper, G. / Meropol, N. J. et al. | 2011
- A431
-
PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic DiseaseKarweit, J. / Nanavati, S. / Van Baardewijk, M. / Wagner, S. / Kotapati, S. et al. | 2011
- A432
-
PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) MeasuresVerjee-Lorenz, A. / Two, R. / Clayson, D. / Miller, F. et al. | 2011
- A433
-
PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal CancerUbago, R. / Castillo, M. A. / Flores, S. / Rodriguez, R. / Beltran, C. et al. | 2011
- A434
-
PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma PatientsZhou, K. R. / Kei, K. M. / Ng, H. M. / Wong, R. S. et al. | 2011
- A435
-
PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated CohortDarba, J. / Perez-Alvarez, N. / Kaskens, L. / Martin, P. et al. | 2011
- A437
-
PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma: Results of the Apex TrialPacou, M. / Gauthier, A. / Abrams, K. / Spencer, M. et al. | 2011
- A438
-
PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data AnalysisClark, O. / Clark, L. G. / Botrel, T. E. / Medina, P. / Paladini, L. / Rosa, B. / Rodrigues, N. / Fortes, A. F. / Castro, A. P. / Faleiros, E. et al. | 2011
- A439
-
PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in ItalyDuran, A. / Spaepen, E. / Lamotte, M. / Lucioni, C. / Kutikova, L. / Pujol, B. / Gozzo, M. / Annemans, L. et al. | 2011
- A440
-
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) PopulationGanguli, A. / Henk, H. / Teitelbaum, A. / Ray, S. et al. | 2011
- A442
-
PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims DatabaseRamsey, S. / Henk, H. / Sullivan, J. / Teitelbaum, A. / Akhras, K. / Sollano, J. / Smith, G. / Chen, C. et al. | 2011
- A443
-
PCN55 The Economic Burden of Adjuvant Chemotherapy in GermanyEiermann, W. / Rezai, M. / Kuemmel, S. / Kü / hn, T. / Benkow, A. / Hogberg, D. / Schweikert, B. / Blohmer, J. U. et al. | 2011
- A444
-
PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow RegionShakhanina, I. / Namazova-baranova, L. / Krasnopolskiy, V. I. / Zarochentseva, N. V. / Kozachenko, V. P. / Demarteau, N. / Shchurov, D. et al. | 2011
- A445
-
PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in CanadaCasciano, R. / Chulikavit, M. / El Ouagari, K. / Wang, X. et al. | 2011
- A446
-
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United KingdomSamyshkin, Y. / Hertel, N. / Griebsch, I. et al. | 2011
- A447
-
PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in TurkeyBakir, M. / Levent, A. / Nagy, L. / Brandtmü / ller, A. / Singhal, P. / Pillsbury, M. / Dasbach, E. et al. | 2011
- A448
-
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)Arreola Ornelas, H. / Rosado Buzzo, A. / Garcí / a, L. / Camacho, L. M. / Lechuga, D. et al. | 2011
- A449
-
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in PolandGadaj, A. / Kalinowska, A. / Hawrylecka, D. / Holojda, J. / Krawcewicz, A. / Spychalowicz, W. / Russel-Szymczyk, M. / Szkultecka-debek, M. et al. | 2011
- A450
-
PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in RussiaTikhomirova, A. V. / Yagudina, R. I. / Kulikov, A. U. et al. | 2011
- A452
-
PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European CountriesRetsa, P. / Sidhu, M. / Odeyemi, I. / Tombal, B. / Wex, J. et al. | 2011
- A453
-
PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung CancerZaim, R. / Gaultney, J. / Redekop, W. / Uyl-de Groot, C. et al. | 2011
- A455
-
PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS): Results From a Retrospective, Multinational European StudyGunther, O. / Body, J. J. / Sleeboom, H. / Hechmati, G. / Pereira, J. / Maniadakis, N. / Terpos, E. / Acklin, Y. P. / Finek, J. / Mossman, T. et al. | 2011
- A456
-
PCN122 Disclosing Traditional & Complementary Medicines (T&CM) Use to the Health Care Providers: A Qualitative Study Among Cancer Patients at a Local Hospital in MalaysiaFarooqui, M. / Hassali, A. / Knight, A. / Akmal, A. / Tan, B. S. / Farooqui, M. A. et al. | 2011
- A457
-
PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel TherapyJames, N. / Eisenberger, M. / Fizazi, K. / Heidenreich, A. / Joulain, F. / Laizet, C. et al. | 2011
- A458
-
PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer TherapyAn, S. M. / Kim, S. H. / Kim, K. S. / Chung, H. S. / Lee, S. K. / Cheon, S. / Lee, S. H. / Park, S. / Kim, E. H. / Eo, W. K. et al. | 2011
- A459
-
PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life: Final ResultsArtal, A. / Oramas, J. / Cobo, M. / Domine, M. / Barneto, I. / Rodrí / guez-Abreu, D. / Menendez-ureñ / a, M. / Andrade, J. et al. | 2011
- A461
-
PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped UtilitiesBatty, A. J. / Fisher, D. / Winn, B. / Wang, Q. / Tolley, K. / Rowen, D. et al. | 2011
- A462
-
PCN154 Discussing the Introduction of National Screening Programs in Greece: A Delphi StudySkroumpelos, A. / Pavi, E. / Kyriopoulos, J. et al. | 2011
- A463
-
PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily PracticeBlommestein, H. / Groen, H. / Smit, E. / Thunnissen, E. / Uyl-de Groot, C. et al. | 2011
- A464
-
PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in EuropeBresse, X. / Largeron, N. / Marty, R. / Roze, S. et al. | 2011
- A465
-
PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in EnglandViejo Viejo, I. / Kilby, S. et al. | 2011
- A466
-
PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN GuidelinesVitezic, D. / Vrdoljak, E. / Bolanca, S. et al. | 2011
- A467
-
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell CarcinomaDe groot, S. / Redekop, W. / Kiemeney, L. / Uyl-de Groot, C. et al. | 2011
- A468
-
PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009Kellermann, L. / Hofheinz, R. D. / Arnold, D. et al. | 2011
- A469
-
PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal CancerTappenden, P. / Brennan, A. / Chilcott, J. / Squires, H. et al. | 2011
- A471
-
PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based StudyHolstein, A. / Patzer, O. M. / Machalke, K. / Holstein, J. D. / Dippel, F. W. / Kovacs, P. et al. | 2011
- A472
-
PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or LiraglutideScott, D. / Boye, K. S. / Timlin, L. / Best, J. H. / Clark, J. et al. | 2011
- A473
-
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)Gottesman, I. / Girard, M. / Shorey, S. et al. | 2011
- A474
-
PDB18 Australia: Management of the Diabetic Foot with Pedimed® Under Real Use ConditionsTaieb, C. / Auges, M. et al. | 2011
- A475
-
PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in ItalyIannazzo, S. / Pradelli, L. / Montagnoli, R. / Militano, L. et al. | 2011
- A476
-
PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in BulgariaBoyanov, M. / Petrova, G. / Henriksen, O. / Valov, V. et al. | 2011
- A477
-
PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK SettingMcDonell, A. / Zammit, D. C. / Haslam, T. / Gregor, Z. / Wilson, B. P. et al. | 2011
- A478
-
PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association: How Much Does Cost-Effective Treatment Cost?Szmurlo, D. / Schubert, A. / Kostrzewska, K. / Rys, P. / Skrzekowska-Baran, I. et al. | 2011
- A479
-
PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal SettingsCarvalho, D. / Lindner, L. / Kozarzewski, M. et al. | 2011
- A480
-
PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease: A Literature-Based AnalysisPatel, D. / Stephens, J. M. / Wiegand, P. / Pulgar, S. et al. | 2011
- A482
-
PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes MellitusMoreira, S. / Almeida, A. / Guerra, P. et al. | 2011
- A483
-
PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) DatabaseAargen, M. / Wu, N. / Boulanger, L. / Lamothe, K. et al. | 2011
- A484
-
PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)Guelfucci, F. / Clay, E. / Aballea, S. / Toumi, M. / Lassalle, R. et al. | 2011
- A485
-
PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes PatientsAl-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. et al. | 2011
- A486
-
PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 DiabetesNagy, B. / Nagyjanosi, L. / Nagyistok, S. / Jó / zwiak-Hagymá / sy, J. / Dessewffy, Z. / Kalo, Z. / Vokó / Z. et al. | 2011
- A487
-
PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc StudyLeiva-Fernandez, F. / Barnestein-Fonseca, P. / Leiva- Fernandez, J. / Vidal-Españ / a, F. / Garcí / a-Ruiz, A. / Prados-Torres, D. et al. | 2011
- A488
-
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic RhinoconjunctivitisRonborg, S. M. / Svendsen, U. G. / Micheelsen, J. S. / Ytte, L. / Andreasen, J. N. / Ehlers, L. et al. | 2011
- A489
-
PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) PerspectiveSuzuki, C. / Silva, N. L. et al. | 2011
- A490
-
PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 YearsJansson, S. A. / Backman, H. / Lindberg, A. / Rö / nmark, E. / Lundbä / ck, B. et al. | 2011
- A492
-
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in AustraliaTilden, D. / Cottrell, S. / Tocchini, L. / Frenzel, C. / Bonney, M. A. et al. | 2011
- A493
-
PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK SettingPaggiaro, P. / Buseghin, G. / Nicolini, G. / Patel, S. / Iannazzo, S. / Zaniolo, O. / Papi, A. et al. | 2011
- A494
-
PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic RhinitisWesterhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Sieber, J. / Augustin, M. et al. | 2011
- A495
-
PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary DiseaseAtsou, K. / Hejblum, G. / Chouaid, C. et al. | 2011
- A496
-
PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)Palsgrove, A. / Houghton, K. / Hareendran, A. / Schaefer, M. / Setyawan, J. / Mocarski, M. / Carson, R. / Make, B. et al. | 2011
- A497
-
PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary DiseaseLeidy, N. / McCormack, J. / Hamilton, A. / Becker, K. et al. | 2011
- A498
-
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary DiseaseAgh, T. / Inotai, A. / Meszaros, A. et al. | 2011
- A499
-
PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to FluoroquinolonesSimoens, S. / Verhaegen, J. / Van Bleyenbergh, P. / Peetermans, W. / Decramer, M. et al. | 2011
- A500
-
PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?Zaniolo, O. / Bettoncelli, G. / Bosio, G. / Mantovani, L. G. / Pistelli, R. / Vaghi, A. / Villa, M. / Iannazzo, S. / Bamfi, F. / Pitrelli, A. et al. | 2011
- A501
-
PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD: The Use of Mixture ModelsStull, D. E. / Houghton, K. / Gale, R. / Wiklund, I. / Capkun-Niggli, G. / Jones, P. et al. | 2011
- A502
-
PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages: Results From an Observational StudyGerlier, L. / Shlaen, R. / Wolfram, C. / Lamotte, M. / Verboven, Y. et al. | 2011
- A503
-
PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic EvaluationMartinez Ferez, I. M. / Flores Moreno, S. et al. | 2011
- A504
-
PSS16 Cost of Blindness in AustriaBrennig, C. / Schö / llbauer, V. / Walter, E. et al. | 2011
- A505
-
PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic SteroidsPadula, W. V. / Yilmaz, T. / Cordero-Coma, M. et al. | 2011
- A506
-
PSS27 We Treat Eyes, Not People: The Systematic Overestimations of Utility in Age-Related Macular Degeneration ModelsVisser, M. S. / Amarakoon, S. / Missotten, T. / Busschbach, J. et al. | 2011
- A507
-
PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity GroupsAcaster, S. / Verboven, Y. / Begley, C. / Chalmers, R. / Abetz, L. / Thompson, T. et al. | 2011
- A508
-
PSS37 the Clinical and Economic Burden of Acute Otitis Media: A Large Prospective Observational Cohort Study in EuropeLiese, J. G. / Giaquinto, C. / Silfverdal, S. A. / Carmona, A. / Larcombe, J. / Garcia-Sicilia, J. / Fuat, A. / Muñ / oz Hiraldo, E. / Arroba Basanta, M. L. et al. | 2011
- A509
-
PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With PsoriasisTabolli, S. / Pagliarello, C. / Sampogna, F. / Di Pietro, C. / Abeni, D. / Centro Studi GISED, I. et al. | 2011
- A511
-
ISPOR 14th annual European congress financial disclosure information for research presetnations| 2011
- A521
-
ISPOR 14th Annual European Congress Research Abstracts Author Index| 2011
- A535
-
EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela: Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)Vieta, E. / Baptista, T. / Bifano, M. / Kerr-Corrê / a, F. / Grohs, G. / de Oliveira, I. / Vielma, X. / Montes, C. / Beluche, S. et al. | 2011
- A536
-
QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En ColombiaAlfonso-Cristancho, R. / Herran, S. / Caicedo, M. / Gomez, E. et al. | 2011
- A537
-
VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En ColombiaRico Mendoza, F. A. / Porras, A. / Alvis, N. / De La Hoz, F. / Cediel, N. / Del Rio, F. et al. | 2011
- A538
-
CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion MedicaQuintana Carrillo, R. / Arrieta Rodrí / guez, O. / Zinser Sierra, J. / Correa Acevedo, M. / Mohar Betancurt, A. / Reynales Shigematsu, L. et al. | 2011
- A539
-
HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in BelizeHeredia Pi, I. B. / Pé / rez Nú / ez, R. / Hijar Medina, M. / Jones, S. / Silveira Rodrigues, E. M. et al. | 2011
- A540
-
IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin AmericaRosado-Buzzo, A. / Garcia-Mollinedo, L. / Camacho-Cordero, L. / Roberts, C. S. / Mould-Quevedo, J. F. / Trejo-Martinez, A. / Luna-Casas, G. et al. | 2011
- A541
-
RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos NeonatalesReyes-Lopez, A. et al. | 2011
- A542
-
PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En ColombiaRuiz, A. / Alfonso-Cristancho, R. / Mejia, A. / Gonzalez, D. / Maestre, K. / Herran, S. et al. | 2011
- A543
-
PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic PainGalindo, L. / Guajardo, J. / Plancarte, R. / Cerezo, O. / Najera, E. / Gonzalez, I. et al. | 2011
- A544
-
PCV4 Analisis Costo Efectividad En El Largo Plazo De Los Stents Liberadores De Farmaco vs Stents Convencionales En Pacientes Con Cardiopatia Isquemica En El ImssGonzalez-Diaz, B. E. / Salinas Escudero, G. / Granados-Garcia, V. / Herná / ndez, I. C. / Abbo, M. C. et al. | 2011
- A545
-
PCV9 Costo–efectividad De Los Ácidos Grasos Omega 3 Como Coadyuvante De La Simvastatina En El Tratamiento De La HipertrigliceridemiaRendon, D. / Ordoñ / ez, J. / Orozco, J. J. et al. | 2011
- A546
-
PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in MexicoZanela, O. O. / Cabra, H. A. / Muñ / oz, D. F. et al. | 2011
- A547
-
PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in MexicoCarlos, F. / Ramí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. / Ramos, E. et al. | 2011
- A548
-
PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)Hé / buterne, X. / Lé / mann, M. / Coteur, G. / Ernault, E. / Colombel, J. F. et al. | 2011
- A549
-
PHP6 Cuadro Básico Y CatÁlogo De Medicamentos Del Sector Salud: Es Actualmente Un referente Para Las instituciones PÚblicas Y/O cumple Con Los Objetivos De Su CreaciónRivera-Peñ / a, G. / Vargas-Palacios, A. / Barraza-Llorens, M. / Gutierrez-Delgado, C. et al. | 2011
- A551
-
PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los CostosMino-Leon, D. / Contreras-Hernandez, I. / Anaya, P. / Reyes, A. et al. | 2011
- A552
-
PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇaPais-Ribeiro, J. / Silva, I. / Pedro, L. / Meneses, R. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Martins-da Silva, A. / Vilhena, E. et al. | 2011
- A553
-
PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community: The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, GhanaAgyei-Baffour, P. / Mantey, K. G. / Owusu-Dabo, E. et al. | 2011
- A554
-
PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and PolandKirpekar, S. / Shankland, B. et al. | 2011
- A555
-
PHP41 Monitoring of HPV Vaccination Effectiveness Within European UnionBielik, J. / Maruš / ková / E. / Glogowski, C. et al. | 2011
- A556
-
PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil: Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticosMota, D. M. / Araú / jo, M. A. / Santos, A. E. / Cunha, T. R. / Silva, S. F. / Bovi, R. F. / Alaver, R. T. / Albo, G. C. / Cunha, J. A. et al. | 2011
- A558
-
PIN2 Facing Critical Health Events: Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010Gutierrez-Delgado, C. / Gó / mez-Fraga, S. et al. | 2011
- A559
-
PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)Morales Buenrostro, L. E. et al. | 2011
- A560
-
PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In SwedenPudas, H. / Hemels, M. / Mehnert, A. / Druais, S. / Martin, M. et al. | 2011
- A561
-
PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro socialClark, P. / Carlos, F. / Chico, G. / Galindo-Suarez, R. M. et al. | 2011
- A562
-
PMS8 Cost-Effectiveness analysis of Etanercept versus Available anti-Tnf and Il-6 Blockers for Treating Rheumatoid Arthritis in GuatemalaLutz, M. / Cuesta, G. / Morales, G. et al. | 2011
- A563
-
PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in BrazilTeich, V. / Chaves, L. / Birnbaum, H. / Pike, C. / Waryas, C. / Cifaldi, M. et al. | 2011
- A565
-
PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term PatientsMayen-Herrera, E. / Buesch, K. / Cortina, D. et al. | 2011
- A566
-
PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar: Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009Heredia, I. / Servá / n, E. / Reynales, L. M. / Bautista, S. et al. | 2011
- A567
-
PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017Guajardo-Barron, V. J. / Gutierrez-Delgado, M. C. et al. | 2011
- A568
-
PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In MexicoArocho, R. / Northridge, K. / Rivera Hurtado, R. / Chavez, J. G. et al. | 2011
- A569
-
PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or HemodialysisMayen-Herrera, E. / Cortes, M. / Marx, S. E. / Sterz, R. et al. | 2011
- A571
-
ISPOR 3rd Latin America conference disclosure information for reserch presentations| 2011
- A573
-
ISPOR 3rd Latin America Conference Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
- I
-
Instructions for Authors| 2011
-
PRM8 Could Corporate Social Responsibility Predict Pharmaceutical Corporate Financial performance?Auamnoy, T. / Areepium, N. et al. | 2011
-
PCN27 Budget Impact Analysis for Chronic Mieloid Leukemia Therapy in BulgariaSavova, A. / Petrova, G. et al. | 2011
-
PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad?Rajan, S. S. / Lyman, G. H. et al. | 2011
-
PCN74 Cost-Effectiveness Analysis of Chemoprevention for Colorectal Cancer by Low Dose Aspirin in South KoreaLee, J. Y. / Lee, E. K. et al. | 2011
-
PCN92 The Cost-Effectiveness of Nanoparticle Albumin-Bound Paclitaxel Compared to Solvent-Based Paclitaxel in Women with Metastatic Breast CancerVandewalle, B. / Almeida, J. / Fé / lix, J. / Silva, M. J. / Luz, R. et al. | 2011
-
PCN97 Economic Evaluation of Prophylactic Pegfilgrastim and Filgrastim in Patients with Myeloablative Chemotherapy to Avoid Neutropenia in the IMSS (Mexican Institute of Social Security)Nambo-Lucio, M. et al. | 2011
-
PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Markov ModelBorget, I. / Vergnenegre, A. / Chouaid, C. et al. | 2011
-
PCN112 Cost-Utility of Treatment for Acute Lymphoblastic Leukemia (ALL) in ChildhoodRae, C. S. / Furlong, W. / Sala, A. / Jankovic, M. / Naqvi, A. / Barr, R. D. et al. | 2011
-
PCN124 The Impact of Condition Labelling on Health State ValuesBrazier, J. / Rowen, D. / Tsuchiya, A. / Young, T. / Ibbotson, R. et al. | 2011
-
PCN127 Health State Utility Assessment for Breast CancerShih, V. / Chan, A. / Xie, F. / Ko, Y. et al. | 2011
-
PCN132 A Development of Quality Indicators for Evaluating Home Palliative Care and Their Relation with Bereaved Family SatisfactionSaito, S. / Shimozuma, K. / Yamaguchi, M. / Ueda, K. et al. | 2011
-
PCN136 Cancer Patients' Perceptions Towards the Integration of Traditional & Complementary Medicines (T&CM) into the Conventional Cancer Treatment: A Qualitative InsightFarooqui, M. / Hassali, M. A. / Knight, A. A. / Akmal, A. / Seang, T. B. / Farooqui, M. A. et al. | 2011
-
PCN153 Cost of Hospital Care in Population of Patients with Neoplasms in PolandMacioch, T. / Paweska, J. / Niewada, M. / Hermanowski, T. R. et al. | 2011
-
PCN163 Funding by SHAs for Rarer Cancers in England: Key Success Factors in the Uptake of Cancer Drugs FundChaudhari, S. D. / Kilby, S. et al. | 2011
-
PCN170 Direct Costs of Head and Neck Cancer in the US: An Analysis Using 2008 Medical Expenditure Panel Survey (MEPS) DataRascati, M. E. / Park, H. / Rascati, K. L. et al. | 2011
-
PCN195 Bayesian Calibration of A Cervical Cancer Model Using Markov Chain Monte CarloWalsh, C. / Ortendahl, J. / Sy, S. / Kim, J. et al. | 2011
-
PCN194 The Use of Large GPs Longitudinal Database in the Reasearch of Causal Associations Among Pathologies: The Case of Diabetes and Cancer IncidenceKatz, P. / Ripellino, C. / Heiman, F. / Chatenoud, L. et al. | 2011
-
PDB9 Weight Loss, Independent of Drug Class, Predicts HbA1c Goal Attainment in Patients 65 Years and Older in a Real-World SettingMcAdam-Marx, C. / Brixner, D. / Ye, X. / Unni, S. / Mukherjee, J. et al. | 2011
-
PDB17 Off-Label and Non-Licensed Endocrinology Medicine Use in Turkey: A Retrospective Analysis of Computer Records in the Turkish Ministry of HealthKockaya, G. / Tanyeri, P. / Vural, x. M. / Akbulat, A. / Akar, H. / Tokaç / M. / Kerman, S. et al. | 2011
-
PDB23 Budget Impact Analysis of the Reimbursement of Long-Acting Insulin Analogues in PolandOrlewska, E. / Gulacsi, L. et al. | 2011
-
PDB74 Title: Implementation of Diabetes Programme Budget Marginal Analysis (PBMA) Exercise in an English Primary Care Trust (PCT)Lim, M. / Anderson, P. M. et al. | 2011
-
PDB81 Assessment of Drug Adherence for Type 2 Diabetes Patients Using Vial or Pen Form Insulin: A Method to Adjust the Traditional Medication Possession RatioWang, L. / Xie, L. / Baser, O. et al. | 2011
-
PRS38 The Cost-Effectiveness of Roflumilast for COPD in SwedenEngströ / m, A. et al. | 2011
-
PRS31 Economic Evaluation of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) from the Public Payer Perspective in BrazilSuzuki, C. / Silva, N. L. et al. | 2011
-
PRS35 Economic Evaluation of Indacaterol Versus Tiotropium or Formoterol for Patients with Moderate to Severe Copd in GreeceGeitona, M. / Hatzikou, M. / Bania, E. et al. | 2011
-
PRS48 Cost-Utility Analysis of Varenicline vs Existing Smoking Cessation Strategies in EL SalvadorLutz, M. A. / Lovato, P. / Morales, G. / Cuesta, G. et al. | 2011
-
PRS61 Age has No Significant Impact on Health-Related Quality of Life in Patients Hospitalized for COPD ExacerbationsAntoniu, S. A. / Puiu, A. / Zaharia, B. G. / Azoicai, D. et al. | 2011
-
PRS65 The Effect of Omalizumab on Unscheduled Healthcare Resource Utilisation and Health-Related Quality of Life in UK Clinical Practice: The Apex StudyBarnes, N. / Radwan, A. / Percival, F. et al. | 2011
-
PRS76 Systematic Literature Review of Conceptual Models to Inform Economic Modelling in COPDGonzalez McQuire, S. / Tabberer, M. / Chambers, M. et al. | 2011
-
PSS6 Epidemiology, Disease Burden, Symptomatology, Treatment Pattern, and Quality of Life in Macular Degeneration in Korea: Systematic Literature Review Based on Korean EvidenceSohn, H. S. et al. | 2011
-
PSS33 Estimation of Meaningful Change on the Skindex-29 and Dermatology Life Quality Index in Patients With Chronic Hand EczemaAugustin, M. / Lloyd, A. J. / Purwins, S. / Diepgen, T. L. et al. | 2011
-
CV1 A Cost-Utility Analysis of Prophylactic Therapy for Venous Thromboembolism with Dabigatran Etexilate or EnoxaparinBurbano-Levy, X. / Herrá / n, S. / Sá / nchez, G. / Mieth, K. / Alfonso-Cristancho, R. et al. | 2011
-
CV3 Análisis De Costo Efectividad En El Cierre De La Comunicación Interatrial Ostium Secundum: Técnica Percutánea Versus QuirúrgicaFlores, A. / Contreras, I. / Alva, E. et al. | 2011
-
EX3 Incremental Cost of Implementing A Care Program for People with Type 2 Diabetes in ArgentinaGonzalez, L. / Caporale, J. E. / Elgart, J. F. / Gagliardino, J. J. et al. | 2011
-
TP2 Patrones De Tratamiento De La Leucemia Mieloide Crónica (Lmc) En Pacientes Resistentes O Intolerantes A Imatinib En Instituciones De Salud Pública En MéxicoHerná / ndez-Rivera, G. / Aguayo-Gonzá / lez, x. / Cantu-Rodrí / guez, O. G. / Cervera, E. / Gomez-Almaguer, D. / Gutié / rrez-Aguirre, C. H. et al. | 2011
-
RM3 A Comparison Between Markov Chains and System Dynamics Modeling for the Estimation of Metabolic Syndrome Costs in a Public Health Care Delivery Organization in MÉxicoOlmedo-Bustillo, C. / Oliva-Oropeza, P. / Rivas-Oropeza, I. / Aranzeta-Ojeda, F. et al. | 2011
-
PDB9 Analisis De Costo–Efectividad Del Uso De Detemir En Diabetes Tipo 2 Frente Al Riesgo De Presentar Eventos Cardiovasculares Y MuerteRomero, M. / Chavez, D. / Karpf, E. / Alvis, N. et al. | 2011
-
PDB6 Educational Interventions in Patients with Type-2 Diabetes Improve Clinical and Metabolic Outcomes and Optimize the Use of Treatment Resources in Argentina: The Prodiacor StudyCaporale, J. E. / Elgart, J. F. / Gonzalez, L. / Rucci, E. / Lapertosa, S. / Villagra, M. / Gagliardino, J. J. et al. | 2011
-
PGI1 Resource Utilization and Cost of Management of Complex Perianal Fistula in Crohn's Disease in SpainBadia, X. / Lara, N. / Garcia-Losa, M. / Zanotti, C. / Orofino, J. et al. | 2011
-
PHP7 Impact of Global Health Care Reforms on Pricing, Access and Health Economics and outcomes StrategyAggarwal, S. et al. | 2011
-
PHP27 The Economic Benefits of Implementing A Unit Dose Drug Dispensing System at the Hospital Level in the Mexican Institute of Social Security (IMSS)Uc-Coyoc, R. / Pé / rez-Reynaud, A. G. / Coello-Reyes, L. A. / Rodriguez-Dí / az Ponce, M. A. et al. | 2011
-
PHP51 Patient-Centered Care: Challenges for Brazil, Lessons for United StatesFreitas, E. L. / Poplavska, E. et al. | 2011
-
PIH3 Resource Use And Associated Costs For The Treatment Of Heavy Menstrual Bleeding With Levonorgestrel Releasing Intrauterine System (LNG-IUS) Versus Hysterectomy: The Brazilian Public Healthcare System (SUS) PerspectiveBahamondes, L. / Bahamondes, V. / Schiola, A. / Silva, A. P. / Santoni, N. B. / Moura, M. / Salem, J. / Clarck, L. / Teich, V. et al. | 2011
-
PRS1 Budget Impact analysis of Fluticasone Furoate (FFNS) in Treatment of Allergic Rhinitis Patients in MexicoRely, K. / Salinas, G. E. / Anaya, P. / Alexandre, P. K. et al. | 2011
-
PSY6 Estudio De COSTO-Efectividad De Buprenorfina TRANSDÉrmica Versus Oxicodona Oral Y Fentanilo TRANSDÉrmico En El Manejo Del Dolor CRÓnico No OncolÓgico En El Hospital San JosÉ De Bogotá D.C. Enero-Diciembre 2010Hinestrosa, F. / Garzon, L. et al. | 2011
-
PC1 The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood DisordersDespié / gel, N. / Danchenko, N. / Franç / ois, C. / Lensberg, B. / Drummond, M. et al. | 2011
-
PR1 Key Market Access Drivers for A Successful Health Technology Appraisal outcome – The Case of Rheumatoid ArthritisAckermann, J. / Urbinati, D. / Strandberg-larsen, M. / Toumi, M. et al. | 2011
-
NI4 The Association between Financial Impact and the likelihood of recommendation of Medicines for Use in England and WalesMauskopf, J. A. / Chirila, C. / Birt, J. / Boye, K. S. / Bowman, L. / Grainger, D. et al. | 2011
-
VI4 the Value of information of A Multicentre Randomised Controlled Trial of intravenous Immunoglobulin for Sepsis (Severe Sepsis and Septic Shock)Soares, M. O. et al. | 2011
-
HT3 Understanding the Complexity of HTA NetworksAndreykiv, M. / Van engen, A. / Wiebinga, C. / Zorzi, O. / Mark, R. et al. | 2011
-
MA2 Mapping Fact-P to Country Specific Patient Health Status Measured by EQ-5D in Metastatic Castrate Resistant Prostate Cancer PatientsSpencer, M. / Diels, J. et al. | 2011
-
PMD40 Cost Effectiveness of Fractional Flow reserve Measurement in Multivessel Coronary Artery Disease in Belgium and FranceBornschein, B. / Arvandi, M. / Gothe, R. / Rioufol, G. / De bruyne, B. / De pouvourville, G. / Desmet, W. / Lefevre, T. / Fearon, W. F. / Pijls, N. H. et al. | 2011
-
PMD45 Optar Study: Transcatheter Aortic Valve Implantation (TAVI) versus Optimal Medical Treatment (OMT) in prohibitive Surgical Risk Patients with Severe Aortic Stenosis (AS) – An Exploratory Cost-Effectiveness AnalysisTeles, R. C. / Almeida, M. / Eaton, J. N. / Watt, M. / Busca, M. R. / Farinha, S. / Mendes, M. et al. | 2011
-
PMD60 Development and Content Validity of the COPD Device Preference QuestionnaireClark, M. / Hofmann, A. / Tabberer, M. / Martin, S. et al. | 2011
-
PMD63 Cost-Benefit analysis of CT Contrast Media (Iopromide) with Prefilled Cartridge Type Compared to Glass Bottle TypeKim, J. / Park, S. / Boo, Y. / Lee, E. / Tang, J. / Jeong, S. et al. | 2011
-
PSU8 Risks and Benefits of Acrysof® Cachet™ Implantation in High Myopia (≥-6 DIOPTRE): A Systematic Literature ReviewSiddiqui, M. K. / Mann, K. / Vonmaltzahn, R. / Ternouth, A. M. / Verboven, Y. / Berdeaux, G. et al. | 2011
-
PSU14 Complications and Costs Associated with Tubal LigationsBrewster, C. / Howard, B. / Lage, M. et al. | 2011
-
PIN6 Clinical Outcomes Analysis Comparing Entecavir with Lamivudine Monotherapy and Lamivudine with “Tenofovir Add-on as Needed” Approach in the Treatment of Chronic Hepatitis B Infection in TurkeyOzdemir, O. / Saylan, M. / Yegnidemir, N. / Lescrauwaet, B. et al. | 2011
-
PIN7 The Comparative Efficacy of Telaprevir Versus Boceprevir in Treatment-Naive and Treatment-Experienced Patients with Genotype 1 Chronic HepatitisDiels, J. / Cure, S. / Gavart, S. et al. | 2011
-
PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination: Findings from a Literature ReviewNewall, A. T. / Jit, M. / Beutels, P. et al. | 2011
-
PIN47 Cost-Effectiveness of Telbivudine in First Line Treatment of HBEAG-Negative Patients with Chronic Hepatitis B (CHB) in the Turkish Healthcare SettingPala, M. / Sahin, U. et al. | 2011
-
PIN52 Cost-Effectiveness of Rifampicin-Based Continuation Phase of Tuberculosis Treatment in UgandaKuznik, A. / Hermans, S. / Castelnuovo, B. / Auerbach, B. / Ssewankambo, F. / Sempa, J. / Ssennono, M. / Lamorde, M. / Semeere, A. / Manabe, Y. C. et al. | 2011
-
PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared with 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in CanadaEarnshaw, S. / Mcdade, C. / Zanotti, G. / Farkouh, R. A. / Strutton, D. et al. | 2011
-
PIN55 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Positive Chronic Hepatitis B in PolandJakubczyk, M. / Pawę / ska, J. / Niewada, M. / Berak, H. / Szkultecka-Dę / bek, M. / Russel-Szymczyk, M. et al. | 2011
-
PIN65 Health Economic Model on the Costs and Effects of Rota Virus Vaccination in GermanyKnoll, S. / Benter, U. / Standaert, B. et al. | 2011
-
PIN67 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Negative Chronic Hepatitis B in PolandJakubczyk, M. / Pawè / ska, J. / Niewada, M. / Berak, H. / Szkultecka-dè / bek, M. / Russel-szymczyk, M. et al. | 2011
-
PIN98 Evaluating Optimal Treatment Outcomes of Antiviral Therapy in Hepatitis C for Prior Null Responders in the Era of First Generation Protease InhibitorsKim, R. W. / Mcewan, P. / Yuan, Y. et al. | 2011
-
PIN113 A New Framework for Understanding the Impact of Hepatitis C and Its Treatment on Quality of LifeArmstrong, A. R. / Duracinsky, M. / Lalanne, C. / Da Silva, M. / Jamal, L. / Herrmann, S. / Carrieri, P. M. / Davril, J. / Chassany, O. et al. | 2011
-
PMH3 Olanzapine Long-Acting Injection for Schizophrenia: An Evaluation of Patient Functioning During 24 Weeks of Maintenance TherapyNovick, D. / Anand, H. / Ascher-Svanum, H. / Haro, J. / Bertsch, J. / Cui, Z. / Detke, H. / Mcdonnell, D. / Montgomery, W. et al. | 2011
-
PMH25 Cost of Delivering Psychiatric Inpatient Care to Mental Health Patients with Psychosis and Co-Occuring Substance Use: A UK-Based StudyShabaruddin, F. H. / Davies, L. M. et al. | 2011
-
PMH38 Buprenorphine/Naloxone Versus Buprenorphine and Methadone in Heroin Addiction Detoxification: An Italian Cost-Utility AnalysisMarino, V. / Lazzaro, C. et al. | 2011
-
PMH52 Relationship Between Psychopathology and Self-Rated EQ-5D Health States Among Patients With SchizophreniaTaha, N. A. / Mohamed Ibrahim, M. I. / Ab Rahman, A. F. / Shafie, A. A. et al. | 2011
-
PMH73 Increasing Use of Medication for Treatment of Attention-Deficcit/Hyperactivity Disorder (ADHD) in Germany between 2003 and 2009Schlander, M. / Schwarz, O. / Trott, G. E. / Banaschewski, T. / Scheller, W. / Viapiano, M. / Bonauer, N. et al. | 2011
-
PMS18 Burden of Rheumatoid Arthritis in the Czech Republic – Direct and productivity CostsKlimes, J. / Vocelka, M. / Dolezal, T. / Petrikova, A. et al. | 2011
-
PMS63 New Developments in the Ankylosing Spondylitis Quality of Life (ASQOL) ScaleMckenna, S. / Wilburn, J. / Crawford, S. / Aryamanesh, M. / Twiss, J. et al. | 2011
-
PMS69 Effectiveness the Treatments with Natural Mineral Water in Low Back Pain for SpondylarthrosisFerreira, M. I. / Silva, A. J. / Almeida, A. et al. | 2011
-
PMS71 A Population Based Assessment of Osteoporosis Prevalence and Treatment in Primary Health Care in Madrid (Spain)Sá / nchez-Piedra, C. / Parody Rú / a, E. / Gonzá / lez-Enrí / quez, J. / Imaz, I. / Sarrí / a Santamera, A. et al. | 2011
-
PND29 Comparing the Cost-Effectiveness of Avonex and Betaferon in the Management of Multiple Sclerosis in IranImani, A. / Golestani, M. / Rasekh, H. et al. | 2011
-
PND40 A Study to Estimate Utility Values for Different Levels of Severity of Migraine PainHareendran, A. / Ng-Mak, D. S. / Stafford, M. R. / Insigna, R. P. / Reifung, X. et al. | 2011
-
PND44 Validation of the Fabry Outcome Survey (FOS) Paediatric Health and Pain QuestionnaireRaluy, M. / Wiklund, I. / Stull, D. E. / Chen, W. H. / Ramaswami, U. / Whybra, C. / Kalkum, G. / Pintos-morell, G. / Parini, R. / Rohrbach, M. et al. | 2011
-
PND50 Public Preferences for the Predictive Genetic Test for Alzheimer'S Disease in the United StatesHuang, M. Y. / Perri, M. et al. | 2011
-
PND68 Social Economic Burden and Health-Related Quality of Life in Patients with Rare Diseases in Europe (BURQOL-RD Project): Methods of Selection of 10 Diseases for A European SurveyLinertová / R. / Ló / pez-Bastida, J. et al. | 2011
-
PUK13 Prevention in Predialitic Stage has Better Results in HealthCarlos, F. / Lechuga, D. et al. | 2011
-
PHP2 Relation Between Consumer Behaviour and Drug Safety Monitoring in FranceFuret, J. / Genane, C. / Ando, G. / Marinoni, G. et al. | 2011
-
PHP35 Is Value Based Pricing Executed In Real Life Situation? – Global PerspectivesMukku, S. / Mallinson, M. et al. | 2011
-
PHP45 Predictability of Pharmaceutical Spending Using Clinical Risk Groups in the Valencian Community in ValenciaUso Talamantes, R. / Caballer Tarazona, M. / Buigues Pastor, L. / Trillo Mata, J. L. / Guadalajara Olmeda, N. / Vivas Consuelo, D. et al. | 2011
-
PHP74 Considerable Potential Savings from Change in Distribution Channel for Serious Diseases Products in Greece: The Case of OGA Social Security Fund (SSF)Georgiadou, G. / Tsikalaki, E. / Makridaki, D. / Argyri, S. / Kousoulou, F. / Geitona, M. et al. | 2011
-
PHP76 The Lack of BIA Methodology in the Czech Republic Leads to Inappropriate Public Health Insurance BudgetingHeislerova, M. / Zizalova, J. / Fuksa, L. / Baloghova, K. et al. | 2011
-
PHP137 Guidelines for Pharmacoeconomic Evaluation for SerbiaNovakovic, T. / Tesic, D. / Stefanovic, D. / Medic, G. / Sovtic, D. et al. | 2011
-
PHP132 Use of a Disease Specific Quality of Life Tool in a Quality Assurance Scheme for Day Case Hernia SurgeryKoch, A. / Lorenz, R. / Wiese, M. G. / Juelicher, P. W. et al. | 2011
-
PHP131 How Can Pharma Industry Prepare Itself for the Changing Pricing and Reimbursement Landscape of Orphan Drugs in EU?Mukku, S. / Pang, F. / Mcconkey, D. et al. | 2011
-
PHP136 Radiology Diagnostics and Interventional Radiology Services Utilization Patterns and Economic Consequences Analysis in a Large Tertiary Care University Hospital – Three Year TrendsJakovljevic, M. / Rankovic, A. / Rancic, N. / Jovanovic, M. / Ivanovic, M. / Gajovic, O. / Lazic, Z. et al. | 2011
-
PHP150 Pharmaceutical Pricing Under Uncertainty: Risk-Sharing ContractsRodriguez-ibeas, R. / Arizti, I. / Antonanzas, F. et al. | 2011
-
PHP163 Pharmaceutical Innovation: Definition, and Mechanisms for RewardHughes, D. et al. | 2011
-
PHP162 Impact of AMNOG on Pharmaceutical Pricing Trends in GermanyAggarwal, S. et al. | 2011
-
PCV6 Comparison of Bleeding Rates between Statin and Statin-Free Patients on Warfarin: A Claims Database ApproachGuerin, A. / Hylek, E. M. / Frois, C. / Ponce de Leon Barido, D. / Marrone, C. / Bae, J. P. / Zhao, Z. et al. | 2011
-
PCV10 Anti-Glycemic Medication Treatment Patterns Among Type II Diabetes Mellitus Patients Initiating Lipid-Altering RegimensSimko, R. J. / Koselleck, D. / Quimbo, R. A. / Cziraky, M. J. / Toth, P. P. et al. | 2011
-
PCV13 Comparing the Effectiveness of Rosuvastatin and Atorvastatin in Preventing Cardiovascular Events for Populations Stratified by Baseline Cardiovascular Risk: Estimates Using the Archimedes ModelSchuetz, C. A. / Van herick, A. / Alperin, P. E. / Peskin, B. R. / Hsia, J. / Gandhi, S. K. et al. | 2011
-
PCV46 Clinical and Economic Burden of Major Bleeding in Abdominal Surgery PatientsBaser, O. / Wang, L. et al. | 2011
-
PCV80 Economic Evaluation of Pravastatin for the Prevention of Coronary Artery Disease in JapanOnishi, Y. / Hinotsu, S. / Nakao, Y. M. / Urushihara, H. / Kawakami, K. et al. | 2011
-
PCV92 Cost Utility of Ranolazine in the Symptomatic Treatment of Patients with Chronic Angina Pectoris in SpainRamos-Goñ / i, J. M. / Hidalgo, A. / Villoro, R. et al. | 2011
-
PCV116 The Impact of High Risk of Stroke Patients Diagnosed with atrial Fibrillation on Health-Related Quality of Life, and Health Care Use in 5EUGupta, S. / Gross, H. / Isherwood, G. et al. | 2011
-
PGI27 Sleep Disturbance and Quality of Life Among Hepatitis C Infected IndividualsWagner, J. S. / Gross, H. J. / DiBonaventura, M. D. et al. | 2011
-
PIH27 Potential Health and Economic Impact of Adding Rotarixtm to Routine Infant Vaccination Programs in CanadaIsmaila, A. / Chu, R. / Standaert, B. et al. | 2011
-
PIH46 Satisfaction with Prescription and Over-the-Counter Medications: Results from a Novel Patient RegistryKamble, S. / Cascade, E. / Cox, T. / Gemmen, E. et al. | 2011
-
PIH48 Assessment of Country-Level Health-Related Quality of Life (HRQL) Outcomes and Treatment Effect of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in Women with Idiopathic MenorrhagiaStull, D. E. / Vanness, D. / Lambrelli, D. / Filonenko, A. / Franke, E. / Wittrup-Jensen, K. et al. | 2011
-
PIH49 Otis: An Aid Tool for the Management of Itchy ScalpsPerrin, P. / Auges, M. / Rahhali, N. / Taieb, C. et al. | 2011
-
PSY32 Modeling Cost-Effectiveness of Drug Treatments for Severe Chronic Non-Cancer Pain in PortugalObradovic, M. / Hertel, N. / Ikenberg, R. / Gouveia, M. / Liedgens, H. et al. | 2011
-
PSY43 The Translation and Linguistic Validation of the Treatment Related Impact Measure – Weight (Trim-Weight)Ellis, G. / Kragh, N. / Brod, M. / Wild, D. et al. | 2011
-
PRM3 Challenges to Obtain Real-Life Data in Observational Studies: What are the Solutions When the Patient is the Main Data Provider?El kebir, S. / Bourhis, Y. / Fournie, X. et al. | 2011
-
PRM24 Scan: An Integrated System for Market Access of New Drugs in ItalyLanati, E. P. / Lidonnici, D. / D'Ausilio, A. / Iorio, A. / Jommi, C. et al. | 2011
-
PRM39 Identification of Diseases for EQ-5D Bolt-on Item Development: An Empirical ApproachSolem, C. T. / Gu, N. Y. / Pickard, A. S. et al. | 2011
-
PRM42 Valuation of HR-QoL Utilities by the EQ-5D in a Group of Chronically Ill PatientsVanhaute, O. A. / Peleman, R. / Annemans, L. et al. | 2011
-
PRM43 Direct from the Patients – Research Into What Patients Would Like to Improve in Their Electronic Diary ExperienceO'Gorman, H. J. / Ross, J. et al. | 2011
-
PRM46 Linguistic Validation and ePRO – Value of CollaborationZarzar, K. M. / Dawsey, R. et al. | 2011
-
PRM50 Sample Size and Ethical Considerations in Randomized Cluster Sampling Versus Individual Patient Recruitment Formulas in Prospective Observational StudiesChiappinelli, R. / Stanley, S. / Criscola, R. / Wasser, T. et al. | 2011
-
PRM54 Model and Covariate Visualization Aids for Enhancing the Interpretation of Steps in the High Dimensional Propensity Scoring Adjustment ProcedureJuneau, P. / Huse, D. M. et al. | 2011
-
PRM65 Should We Aggregate Cost-Effectiveness over an Intervention's Entire Implementation Lifetime?O'Mahony, J. et al. | 2011
-
PCN10 Comorbid Cardiovascular Diseases in Patients with Metastatic Colorectal CancerOverbeek, J. A. / Zhao, Z. / van Herk-Sukel, M. P. / Barber, B. / Gao, S. K. / Herings, R. M. et al. | 2011
-
PCN62 Costs and Consequences of HPV Vaccination in Thailand: Results of a Prevalence Based ModelVan Enckevort, P. / Kongngamkam, K. / Van Kriekinge, G. et al. | 2011
-
PCN89 Public Health Impact of Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Sao Paulo, Brazil Using A Transmission Dynamic ModelSinghal, P. / Tannus, G. / Pillsbury, M. / Dasbach, E. et al. | 2011
-
PCN111 Cost-Effectiveness of Human Papillomavirus Vaccination for Prevention of Cervical Cancer in Roraima, A Brazilian Amazonic Region StateBalbinotto, G. / Jardim, A. et al. | 2011
-
PCN131 Systematic Evaluation of Specific Quality of Life Instruments for Prostate CancerSchmidt, S. / Pardo, Y. / Vilagut, G. / Garin, O. / Pont, A. / Cunillera, O. / Becerra, V. / Ferrer, M. et al. | 2011
-
PCN135 Influence of Economic Implications Related to the Prescription of Oral and Intravenous Chemotherapy on Physicians' Preferences: A Discrete Choice ExperimentBenjamin, L. / Cotté / F. E. / Philippe, C. / Mercier, F. / Bachelot, T. / Vidal-Tré / can, G. et al. | 2011
-
PCN147 Health-Related Quality of Life in Head and Neck Cancer Patients - Comparison with General Population NormsLahtiharju, T. / Mä / kitie, A. A. / Saarilahti, K. / Bä / ck, L. / Rä / sä / nen, P. / Sintonen, H. et al. | 2011
-
PCN150 Willingness to Pay for A Reduction in Risk of Treatment Side Effects in Patients with Metastatic Breast CancerLalla, D. / Mclaughlin, T. / Brammer, M. / Bramley, T. / Bare, A. / Carlton, R. et al. | 2011
-
PCN160 Prostate Cancer Screening Practices in the Republic of Ireland- The Determinants of UptakeBurns, R. / Walsh, B. / Sharp, L. / O'Neill, C. et al. | 2011
-
PCN176 Cancer Drug Prices in the United States and the United Kingdom: Implications for Pricing Strategy and Drug AccessAggarwal, S. et al. | 2011
-
PCN179 Clinical Trials in Oncology in GreeceMylona, K. / Kyriopoulos, J. et al. | 2011
-
PDB12 Glargine Utilisation in Russia: A Prospective Study to Evaluate Patients Switched from NPH Insulin to Insulin Glargine Compared with Those Maintained on NPHSkudaev, S. / Verbovaya, N. et al. | 2011
-
PDB15 Use of Hypoglicemic Drugs in Serbia: Pharmacotherapeutic Versus Pharmacoeconomic AspectsSabo, A. / Tomic, Z. et al. | 2011
-
PDB44 An Economic Evaluation of the Use of Pioglitazone in Italy Using ProactiveGladwell, D. / Capri, S. / Fionda, A. / Massi-Beneddeti, M. et al. | 2011
-
PDB52 Adherence with Oral Medications for Diabetes Among Brazilian Patients: A Systematic Review of National LiteratureTakemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Cukier, F. N. / Cruz, R. B. / Santos, P. M. / Ribeiro, A. C. / Fernandes, R. R. / Moretti, A. I. et al. | 2011
-
PDB59 Nocturnal Hypoglycemic Events: Impacts on Patients Functioing, Well-Being and Diabetes ManagementBrod, M. / Wolden, M. / Pohlman, B. / Christensen, T. et al. | 2011
-
PRS21 Resource Utilization and Associated Costs of Community Acquired Pneumonia (CAP) in Adults: Observational Study in a Population Setting in a Well Defined Area of Barcelona (Badalona, Spain)Sicras-Mainar, A. / Guijarro, P. / de Salas-Cansado, M. / Cifuentes-Otero, I. / Navarro-Artieda, R. et al. | 2011
-
PRS23 High Cost Cystic Fibrosis Patients as Identified in a Us Claims Database: A Closer Look at the TailHarrow, B. / Becker, C. C. / Buikema, A. et al. | 2011
-
PRS27 Trends in Uk Smoking Cessation Prescription Expenditure Over Time - a Thin Database StudyBlak, B. T. / Lee, J. / Dungarwalla, M. et al. | 2011
-
PRS59 Quality of Life in Severe Persistent Uncontrolled Asthma: Patients and Caregivers in the Spanish Pediatric Population: A Prex StudyGalera, J. / Lahoz, R. / Herrá / ez, L. / Casafont, J. / Plaza, A. / Vennera, M. et al. | 2011
-
PRS68 A Systematic Review of Chronic Rhinosinusitis in Asia-Pacfic and the Role of Balloon SinuplastyMcElroy, H. J. / Belarbi, S. / Foteff, C. / Metz, L. / Chung, L. / Levine, H. L. / O' / Leary, B. A. et al. | 2011
-
PSS10 Economic Outcomes of Glaucoma Treatment With Prostaglandin Eye Drops Preserved With Polyquad® Instead of Benzalkonium Chloride in GermanyGerlier, L. / Lamotte, M. / Lorenz, K. / Berdeaux, G. / Verboven, Y. / Pfeiffer, N. et al. | 2011
-
PSS13 Economic Burden of Psoriasis and Diabetes in Patients With Psoriasis in the United StatesGuerin, A. / Latremouille-Viau, D. / Day, R. / Khan, Z. / Zhang, F. et al. | 2011
-
PSS18 Direct Economic Burden of Regular Intravitreal Injections for the Treatment of Retina Diseases in Three European CountriesJohnson, M. K. / Lara, N. et al. | 2011
-
QA2 Analisis De Costo-Utilidad De Rituximab Posterior Al Fallo Por Anti-Tnf En Artritis Reumatoide Para ColombiaRomero, M. / Latorre, M. / Alvarado, C. / Karpf, E. / Alvis, N. et al. | 2011
-
HS2 Analisis De Costos Del Programa Ampliado De Inmunizaciones En Colombia 2009Romero, M. / Arango, C. / Chavez, D. / Otero, J. / Alvis, N. et al. | 2011
-
PDB7 Cost-Effectiveness of Saxagliptin Treatment in Three Latin American CountriesElgart, J. F. / Caporale, J. E. / Aiello, E. C. / Waschbusch, M. / Jotimliansky, L. / Gagliardino, J. J. et al. | 2011
-
PGI3 AdaptaciÓn De Un ANÁlisis De Costo-Efectividad Del Entecavir vs InterferÓn Pegilado Alfa a VenezuelaOrozco, J. J. / Valencia, J. E. / Aiello, E. / Baquero, E. et al. | 2011
-
PIH4 Analisis De Costo-Efectividad Del Uso De Levonorgestrel-Uis Frente A Otros Tratamientos En Menorragia IdiopaticaRomero, M. / Arango, C. / Espinel, F. / Karpf, E. / Sanabria, M. / Alvis, N. et al. | 2011
-
PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICOVargas-Valencia, J. J. / Sotelo-Guzmá / n, M. / Dí / az-Ponce, H. / Galindo-Suá / rez, R. M. / Muciñ / o-Ortega, E. / Mould-Quevedo, J. F. et al. | 2011
-
PMS10 Cost-Effectiveness of Duloxetine Compared to Pregabaline in Patients with Fibromyalgia from the Public Health Care System perspective in MéxicoRamí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. et al. | 2011
-
PMS11 review of the Studies on Economic Evaluation of Treatment for Postmenopausal OsteoporosisBrandã / o, C. M. / Acurcio, F. D. et al. | 2011
-
PMS12 Evaluacion Economica De Rituximab versus anti-Tnf En Pacientes Con Artritis reumatoide Y Falla Previa A anti-Tnf En MéxicoCarlos, F. / Clark, P. et al. | 2011
-
PSS1 Evaluacion Economica De Fototerapia De Banda Angosta O Fotoquimioterapia Para El Tratamiento De Psoriasis Desde La Perspectiva Del Instituto Mexicano Del Seguro SOCIALCarlos, F. / Ramos, E. / Llorens, F. / Ruiz, L. et al. | 2011
-
PSY1 Epidemiology And Socioeconomic Burden Of Overweight And Obesity In ArgentinaElgart, J. F. / Gonzalez, L. / Caporale, J. E. / Pfirter, G. / Gagliardino, J. J. et al. | 2011
-
DA2 A Choice that Matters: Comparing Methods of Data Synthesis in Cost-Effectiveness ModellingVemer, P. / Al, M. / Oppe, M. / Rutten-Van Mö / lken, M. et al. | 2011
-
HT4 What Determines the Recommendations Issued by Polish Health Technology Agency (AHTAPol)?Niewada, M. / Polkowska, M. A. / Jakubczyk, M. / Golicki, D. et al. | 2011
-
MA4 Modelling EQ-5D Health State Values: Developing A Limited Dependent Variable, Mixture Modeling ApproachWailoo, A. J. / Herná / ndez, M. / Ara, R. et al. | 2011
-
RS4 The Interim Cancer Drugs Fund - How To Not Spend £50 MillionTimm, B. / Brooks-Rooney, C. / Hamerslag, L. / Costello, S. et al. | 2011
-
PMD19 Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-up Data (MADIT II)Gandjour, A. / Holler, A. / Adarkwah, C. C. et al. | 2011
-
PMD41 Drug Eluting Stent (DES) versus Bare Metal Stent (BMS) on Clinical, Humanistic and Economic outcomes: A 12-Month Prospective Observational StudyLee, V. / Yan, B. / Lau, J. C. / Tang, W. K. / Yu, C. M. et al. | 2011
-
PMD61 The Effects of Subjective Insomnia Pattern on the quality of Life of the Climacteric Women in TaiwanWu, H. C. / Lai, J. N. / Hwang, J. S. et al. | 2011
-
PMD62 Validation of A Patient-Reported Outcome (PRO) Measure and A Clinician-Reported Outcome (CRO) Measure to assess Satisfaction and Preference with Pharmacological Stress Agents for Single Photon Emission Computed tomography (SPECT) Myocardial Perfusion Imaging (MPI)Hudgens, S. / Kothari, S. et al. | 2011
-
PMD69 Treatment of Urinary Tract infections is Common amongst Swedish Patients in Need of Chronic CatheterisationBruce, S. / Lö / froth, E. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. et al. | 2011
-
PSU24 Comparison of the Responsiveness of the SF-36 and the Raw and Rasch-Based Scores of the Oxford Knee Score in Patients Undergoing Total Knee ReplacementKo, Y. / Lo, N. N. / Yeo, S. J. / Yang, K. Y. / Chong, H. C. / Yeo, W. / Thumboo, J. et al. | 2011
-
PSU28 Economic Impact of Stereotactic Radiosurgery for Malignant Intracranial Brain TumorsLal, L. / Franzini, L. / Panchal, J. / Chang, E. / Meyers, C. A. / Swint, J. M. et al. | 2011
-
PIN5 Patient and Clinician Perceived Benefit of Early Consumption of Famciclovir for the Treatment of Herpes OutbreaksTwiss, J. / Mckenna, S. / Bloch, M. / Bonney, M. A. et al. | 2011
-
PIN14 Prescribing Patterns of Sebivo® (Telbivudine): A Survey Among Physicians in Selected European CountriesAponte torres, Z. / Lara, N. / Primatesta, P. / Trylesinski, A. et al. | 2011
-
PIN16 Rates and Predictors of Gonorrhea Re-Screening Among Privately Insured Patients with Gonorrhea in 2007-2009Shi, L. / Liu, J. / Kissinger, P. / Khan, M. / Wu, E. Q. et al. | 2011
-
PIN75 Cost-Effectiveness of Polysaccharide Pneumococcal Vaccination in People Aged 65 and Above in PolandGrzesiowski, P. / Soluch, S. / Adamczyk, K. / Durand, L. / Aguiar-Ibá / ez, R. / Martin, M. / Puig, P. E. et al. | 2011
-
PIN97 How Does Health-Related Quality of Life Relate to Symptoms Experience in HIV Patients Treated with Highly-Active Antiretroviral Therapy?Lalanne, C. / Armstrong, A. R. / Herrmann, S. / Chassany, O. / Duracinsky, M. et al. | 2011
-
PIN109 Modelling the Policy of Managing Seasonal Influenza in the UKVan Bellinghen, L. A. / Van Vlaenderen, I. / Meier, G. C. et al. | 2011
-
PMH22 Economic Burden of Attention Deficit Hyperactivity Disorder in Children and Adolescents in EuropeTaneja, A. / Ahuja, A. / Kataria, A. / Kaushik, P. / Kumar, P. et al. | 2011
-
PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in SpainDilla, T. / O'Donohoe, P. / Mö / ller, J. / lvarez, M. / Sacristá / n, J. / San, L. / Happich, M. / Tockhorn, A. et al. | 2011
-
PMH50 Differences Between Opioid Dependent Patients in Italy and Germany Receiving Substitution TherapySevert, J. / Tkacz, J. / Ruetsch, C. et al. | 2011
-
PMH48 The Spanish Version of the Clinically Useful Depression Outcome Scale: A Valid Instrument to Evaluate Depressive Symptoms in Primary CareAgü / era, L. / Monton, C. / Medina, E. / Cuervo, J. / Rodrí / guez Aguilella, A. / Maurino, J. et al. | 2011
-
PMH55 An Examination of Antidepressant-Related Sexual Dysfunction and Degree of Enjoyment and Satisfaction with Daily Activities, and Current Medication in Employed PatientsSchneider, G. / Roy, A. / Dabbous, O. H. et al. | 2011
-
PMH59 Employment Status and Self reported Quality of Life in Chinese Patients Receiving Treatment for Major Depressive DisorderXue, H. B. / Wu, S. H. / Brnabic, A. J. / Novick, D. / Kadziola, Z. / Granger, R. E. / Montgomery, W. et al. | 2011
-
PMH63 Stay Healthy Through Game-Care Therapeutics: It's Time to Play the Game!Aggarwal, A. et al. | 2011
-
PMH67 Drug Utilisation Adaptations in Sweden After the Effexor Patent ExpiryBruce, S. / Hjelmgren, J. / Lö / froth, E. / Myré / n, K. J. et al. | 2011
-
PMH72 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length of Hospitalisation of Patients with Acute Bipolar ManiaBonafede, M. / Locklear, J. C. / Wahlqvist, P. / Fajutrao, L. / Szamosi, J. / Pan, K. / Eriksson, H. et al. | 2011
-
PMS4 Efficacy and Effectiveness of Collagenase Clostridium Histolyticum for Dupuytren'S ContractureSkodny, P. / Mackowiak, J. I. / Peimer, C. et al. | 2011
-
PMS17 The Effect of Biological Treatment on Work Productivity and Productivity Costs of Rheumatoid Arthritis PatientsKlimes, J. / Dolezal, T. / Vocelka, M. / Petrikova, A. / Kruntoradova, K. et al. | 2011
-
PMS26 Cost of Dupuytren Contracture in the Czech RepublicSkoupá / J. / Há / jek, P. et al. | 2011
-
PMS28 Retrospective Chart Review to Assess Utilization of Resources and Costs Related to Postmenopausal Osteoporotic Fractures in Slovenia, Serbia and BulgariaRutkowski, J. / Haldas, M. / Bolisega, D. / Jedynasty, K. / Kozlevcar Zivec, M. / Komadina, R. / Bumbasirevic, M. / Popivanov, P. et al. | 2011
-
PMS39 Economic Evaluation of Tocilizumab for the Treatment of Systemic Juvenile Idiopathic Arthritis in MexicoCarlos, F. / Clark, P. / Lechuga, D. et al. | 2011
-
PMS58 Pilot Validation of the Brief Fatigue Inventory ‘Fatigue at its Worst’ Item in Patients with Rheumatoid ArthritisNaegeli, A. N. / Sterling, K. L. et al. | 2011
-
PMS60 Experiences of Patients with Rheumatoid Arthritis in the US and UK: A Cross-Cultural ComparisonSterling, K. L. / Bush, E. N. / Naegeli, A. / Swinburn, P. / Gallop, K. / Nixon, A. et al. | 2011
-
PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled StudyPope, J. / Fleischmann, R. / Dougados, M. / Bingham, C. O. / Massarotti, E. / Wollenhaupt, J. / Duncan, B. / Coteur, G. / Weinblatt, M. E. et al. | 2011
-
PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, CanadaRoussy, J. P. / Bessette, L. / Bernatsky, S. / Rahme, E. / Lé / garé / J. / Lachaine, J. et al. | 2011
-
PND15 Economic Burden of Chronic Migraine in TaiwanTang, C. H. / Chen, Y. C. / Wang, S. J. / Ng, K. et al. | 2011
-
PND17 Treatment Experience, Burden, and Unmet Needs (Tribune) in Multiple Sclerosis Study: Excess Burden Due to RelapsesKarampampa, K. / Gustavsson, A. / Miltenburger, C. / Eckert, B. et al. | 2011
-
PND38 International Comparison of Huntington Disease (HD) BurdenDorey, J. / De Nicola, N. / Tedroff, J. / Squitieri, F. / Clay, E. / Verny, C. / Zielonka, D. / Cohen, J. / Aballea, S. / Lamure, M. et al. | 2011
-
PND52 Responsiveness of the Multiple Sclerosis International Quality of Life and Short Form-36 Questionnaires to Expanded Disability Status Scale Score Changes in Subjects with Multiple Sclerosis: Final 24-Month Results From An International Observational StudyFernandez, O. / Baumstarck-Barrau, K. / Butzkueven, H. / Flachenecker, P. / Idiman, E. / Pelletier, J. / Stecchi, S. / Verdun di Cantogno, E. / Milner, A. / Auquier, P. et al. | 2011
-
PUK15 A Simulation Model of The Effects of Treatments for Secondary Hyperparathyroidism on MortalityIannazzo, S. / Pradelli, L. / Chiroli, S. / Pé / tavy, F. / Briggs, A. et al. | 2011
-
PHP6 Regional Variability in the Generic Antidepressant Market in SpainEspinó / s, B. / Vieta, A. / Hurtado, P. / Badia, X. et al. | 2011
-
PHP13 A Survey of Pricing Trends Around the WorldReinaud, F. / Ando, G. et al. | 2011
-
PHP15 Price Negotiations in Korean Pharmaceutical Benefit System: How Compatible with CEA?Kwon, H. et al. | 2011
-
PHP16 Extrapolating Strategic Insights Through Market Segmentation: A Conceptual FrameworkForster, L. / Wild, L. et al. | 2011
-
PHP24 How Does the Committee to Evaluate Drugs (CED) Make Decisions about Ambulatory Pharmaceutical Funding in Ontario?Sim, J. / Speicher, J. / Evans, G. / Mahar, A. L. / Johnson, A. et al. | 2011
-
PHP27 Diffusion of Innovations in Health Care: Does the Dual Market Phenomenon Exist?Arbel, R. / Yogev, G. / Greenberg, D. et al. | 2011
-
PHP38 Market Access for Pharmaceuticals in UK: Number and Speed of Drug Reviews to Improve After Introduction of Value Based PricingIzmirlieva, M. A. / Ando, G. / Bharath, A. et al. | 2011
-
PHP55 A Review of the Nice Appeals ProcessEaton, J. N. / Hawkins, N. et al. | 2011
-
PHP66 Impact of Type of Drug Insurance on the Use of Health Care Services Among Users of AntidepressantsBlais, L. / Perreault, S. / Lalonde, L. / Bé / rard, A. / Moisan, J. / Rahme, E. et al. | 2011
-
PHP98 Exploring Regional Variation in Tariffs/Public Prices Across Autonomous Communities in Spain: The Case of Diagnosis Related Groups and ICD-9 Diagnostic CodesRaluy, M. / De Cock, E. / Rovira, J. / Gimenez, E. / Albarracin, M. G. et al. | 2011
-
PHP105 Cost-Effectiveness in Drug Reimbursement Decision Making: A Toothless Tiger?Franken, M. / Sandmann, F. / Koopmanschap, M. et al. | 2011
-
PHP125 Clinical Trial Learning Curves May Impact Both Clinical and Economic Outcomes, and Influence Health Technology Assessment and Reimbursement Decision MakingSpinner, D. S. / Mladsi, D. M. / Walter, J. W. / Stafford-Smith, M. / Taekman, J. M. / Faulkner, E. C. et al. | 2011
-
PHP130 Using Economic Evidence and Stakeholder'S Participation in Decision Making on Benefit Package of Public Health insurance in ThailandPachanee, K. / Mohara, A. / Teerawattananon, Y. / Tantivess, S. / Lertiendumrong, J. / Prakongsai, P. et al. | 2011
-
PHP148 Global Pharmaceutical Risk-Sharing Agreement Trends in 2010 and 2011Ando, G. / Reinaud, F. / Bharath, A. et al. | 2011
-
PHP156 Novel Drug Reimbursement Models: Lessons and Implications from Cancer Drug Access SchemesAggarwal, S. et al. | 2011
-
PCV8 Effect of SIADH on Patient Outcomes and Health Care Resource Utilization in Hospitalized PatientsAmin, A. / Deitelzweig, S. / Lin, J. / Christian, R. / Baumer, D. / Lowe, T. et al. | 2011
-
PCV12 Differences in the Weighted Average Daily Doses of Statins in Europe and Their Potential Impact on Cardiovascular OutcomesLiew, D. / Webb, K. et al. | 2011
-
PCV20 Duration of Action of Aliskiren in Hypertensive Patients with Diabetes – Implications for Control of Blood Pressure in Real-World Use in Imperfectly Adherent PatientsLowy, A. / Brede, Y. et al. | 2011
-
PCV43 Budget Impact of the Implementation of a Treatment Protocol for Pulmonary Arterial Hypertension in A Referral HospitalVega-Coca, M. D. / Flores, S. / Bautista, J. et al. | 2011
-
PCV83 A Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome in GreeceKritikou, P. / Yfantopoulos, J. et al. | 2011
-
PCV114 Preferences for Communication Outcomes Following a StrokeDavies, L. M. et al. | 2011
-
PCV121 The Economic and Humanistic Burden of Acute Coronary Syndrome (ACS): A Systematic ReviewWeir, S. / Ratcliffe, M. / Mollon, P. / Langham, S. / Ossa, D. et al. | 2011
-
PCV126 Multidimensional Non-Interventional Study to Assess Current Practice, Utilization of Resources and Costs Related to Anticoagulation Treatment in Poland – “Economedica”Wilczynska, J. / Haldas, M. / Bolisega, D. / Rutkowski, J. / Smaga, A. / Wladysiuk, M. et al. | 2011
-
PCV127 Time to Initiation of Oral Antihyperglycaemic and Statin Therapy in Patients with Newly Diagnosed Type 2 Diabetes MellitusTunceli, K. / Sun, P. / Seck, T. / Ambegaonkar, B. / Lento, K. / Davies, M. J. / Zhang, Q. / Radican, L. et al. | 2011
-
PCV136 Factors Associated with Failing to Achieve Low Density Lipoprotein Cholesterol Goal with Existing Statin Therapy: A Chart Extraction-Based ApproachZhao, Z. / Ivanova, J. / Bae, J. P. / Boykin, S. D. / Mccracken, R. / Molife, C. / Waldman, T. / Frois, C. et al. | 2011